FDA Inspection 1253990 — OneBlood, Inc.

OneBlood, Inc. — FEI 1070196

The FDA completed an inspection of OneBlood, Inc. on Jun 6, 2025 in St Petersburg, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jun 6, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Blood and Blood Products
Location
St Petersburg, FL (United States)

Citations

IDCFRDescription
922521 CFR 606.171Biological product deviation report

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.